Key Viral Hepatitis Studies From EASL 2022

Source: 2022 Annual Meeting of the European Association for the Study of the Liver*
Download Slideset
June 22-26, 2022; London, United Kingdom
Read expert faculty members’ summaries of HBV, hepatitis delta virus (HDV), and HCV, including data on investigational HBV agents, progress toward HBV cure, emerging treatments for HDV, and HCV treatment implementation in treatment-experienced patients.
Tarik Asselah, MD, PhD
Stefan Zeuzem, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 259 KB
Released: July 6, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings